Amgen’s $4 Billion Senior Unsecured Notes Offerings

Latham & Watkins represented Amgen in the offerings.Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes offerings…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now